• SENSEX
    NIFTY 50
Healthcare

Dr Reddy's gets 8 observations from USFDA for its Duvvada facility

Updated : August 21, 2019 08:49 AM IST

The audit of the company's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug Administration (USFDA) completed on Tuesday, Dr. Reddy's said in a filing to the BSE.
The FDA Form 483 notifies the company's management of objectionable conditions.
Dr Reddy's gets 8 observations from USFDA for its Duvvada facility
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV